Genencell Co., Ltd.
PrivateLast Round
Convertible Debt
Oct 20, 2021
Total Funding Raised
$4.23M
Company Overview
Genencell Co., Ltd. operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Convertible Debt round in October 2021.
Genencell Co., Ltd. is a biotechnology company that researches and develops medicines based on natural materials, health functional foods, and functional cosmetics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices, Fashion & Beauty
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genencell Co., Ltd. Comparables
Compare Genencell Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MThera Pharma | 74% | |
| Bichedam Co., Ltd. | 67% | |
| Mediforum Co., Ltd | 66% |
For institutional investors. Book with your work email.
Genencell Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Oct 20, 2021 | ||||
| VC Round | Feb 3, 2021 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 20, 2021
$4.23M round led by Sejong Medical Co., Ltd.
- Feb 3, 2021
$2.7M round led by KOREA PHARMA Co., Ltd.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_issues_withSep 8, 2026
Genencell faces renewed scrutiny over bribery allegations involving its request for approval to conduct COVID-19 treatment clinical trials in 2021.
For institutional investors. Book with your work email.
Genencell Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genencell Co., Ltd.'s valuation, stock price, and market status.
Is Genencell Co., Ltd. a public or private company?
Genencell Co., Ltd. is a private company.
What is the current stock price of Genencell Co., Ltd.?
Genencell Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Genencell Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genencell Co., Ltd. worth (valuation)?
Valuation information for Genencell Co., Ltd. is not publicly available.
Can I buy Genencell Co., Ltd. stock?
Genencell Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genencell Co., Ltd.'s last funding round?
Genencell Co., Ltd.'s most recent funding round was Convertible Debt on October 20, 2021.
Who are the main investors in Genencell Co., Ltd.?
Investor information for Genencell Co., Ltd. is not publicly disclosed.
Will Genencell Co., Ltd. IPO soon?
No public IPO plans have been announced for Genencell Co., Ltd..
How can I track Genencell Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Genencell Co., Ltd.'s shares on secondary markets.